Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 30 results.
User Information
Export Records
  1. 1.   Rare germline variants in known melanoma susceptibility genes in familial melanoma
  2. Goldstein, Alisa M.; Xiao, Yanzi; Sampson, Joshua; Zhu, Bin; Rotunno, Melissa; Bennett, Hunter; Wen, Yixuan; Jones, Kristine; Vogt, Aurelie; Burdette, Laurie; Luo, Wen; Zhu, Bin; Yeager, Meredith; Hicks, Belynda; Han, Jiali; De Vivo, Immaculata; Koutros, Stella; Andreotti, Gabriella; Beane-Freeman, Laura; Purdue, Mark; Freedman, Neal D.; Chanock, Stephen J.; Tucker, Margaret A.; Yang, Xiaohong R.
  3. Human Molecular Genetics. 2017, Dec 15; 26(24): 4886-4895.
  1. 2.   HER2-Affitoxin: A Potent Therapeutic Agent for the Treatment of HER2-Overexpressing Tumors
  2. Zielinski, R.; Lyakhov, I.; Hassan, M.; Kuban, M.; Shafer-Weaver, K.; Gandjbakhche, A.; Capala, J.
  3. Clinical Cancer Research. 2011, Aug; 17(15): 5071-5081.
  1. 3.   Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas
  2. Kummar, S.; Gutierrez, M. E.; Chen, A.; Turkbey, I. B.; Allen, D.; Horneffer, Y. R.; Juwara, L.; Cao, L.; Yu, Y. K.; Kim, Y. S.; Trepel, J.; Chen, H.; Choyke, P.; Melillo, G.; Murgo, A. J.; Collins, J.; Doroshow, J. H.
  3. European Journal of Cancer. 2011, May; 47(7): 997-1005.
  1. 4.   Interferon-gamma links ultraviolet radiation to melanomagenesis in mice
  2. Zaidi, M. R.; Davis, S.; Noonan, F. P.; Graff-Cherry, C.; Hawley, T. S.; Walker, R. L.; Feigenbaum, L.; Fuchs, E.; Lyakh, L.; Young, H. A.; Hornyak, T. J.; Arnheiter, H.; Trinchieri, G.; Meltzer, P. S.; De Fabo, E. C.; Merlino, G.
  3. Nature. 2011, Jan; 469(7331): 548-U129.
  1. 5.   HER2-and EGFR-Specific Affiprobes: Novel Recombinant Optical Probes for Cell Imaging
  2. Lyakhov, I.; Zielinski, R.; Kuban, M.; Kramer-Marek, G.; Fisher, R.; Chertov, O.; Bindu, L.; Capala, J.
  3. Chembiochem. 2010, Feb; 11(3): 345-350.
  1. 6.   Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment
  2. Weiss, J. M.; Back, T. C.; Scarzello, A. J.; Subleski, J. J.; Hall, V. L.; Stauffer, J. K.; Chen, X.; Micic, D.; Alderson, K.; Murphy, W. J.; Wiltrout, R. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(46): 19455-19460.
  1. 7.   One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia
  2. Lee, K. M.; Lan, Q.; Kricker, A.; Purdue, M. P.; Grulich, A. E.; Vajdic, C. M.; Turner, J.; Whitby, D.; Kang, D.; Chanock, S.; Rothman, N.; Armstrong, B. K.
  3. Human Genetics. 2007, Dec; 122(5): 525-533.
  1. 8.   ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence
  2. Ha, L.; Ichikawa, T.; Anver, M.; Dickins, R.; Lowe, S.; Sharpless, N. E.; Krimpenfort, P.; DePinho, R. A.; Bennett, D. C.; Sviderskaya, E. V.; Merlino, G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Jun; 104(26): 10968-10973.
  1. 9.   Expression of EIF3-p48/INT6, TID1 and Patched in cancer, a profiling of multiple tumor types and correlation of expression
  2. Traicoff, J. L.; Chung, J. Y.; Braunschweig, T.; Mazo, I.; Shu, Y. M.; Ramesh, A.; D'Amico, M. W.; Galperin, M. M.; Knezevic, V.; Hewitt, S. M.
  3. Journal of Biomedical Science. 2007, May; 14(3): 395-405.
  1. 10.   The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems
  2. Goldsmith, M. E.; Aguila, A.; Steadman, K.; Martinez, A.; Steinberg, S. M.; Alley, M. C.; Waud, W. R.; Bates, S. E.; Fojo, T.
  3. Molecular Cancer Therapeutics. 2007, Feb; 6(2): 496-505.
  1. 11.   Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors
  2. Khan, T.; Stauffer, J. K.; Williams, R.; Hixon, J. A.; Salcedo, R.; Lincoln, E.; Back, T. C.; Powell, D.; Lockett, S.; Arnold, A. C.; Sayers, T. J.; Wigginton, J. M.
  3. Journal of Immunology. 2006, MAY 15; 176(10): 6302-6312.
  1. 12.   Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure
  2. Liu, J.; Xie, Y. X.; Ducharme, D. M. K.; Shen, J.; Diwan, B. A.; Merrick, B. A.; Grissom, S. F.; Tucker, C. J.; Paules, R. S.; Tennant, R.; Waalkes, M. P.
  3. Environmental Health Perspectives. 2006, MAR; 114(3): 404-411.
  1. 13.   Generation and characterization of telomere length maintenance in tankyrase 2-deficient mice
  2. Chiang, Y. J.; Nguyen, M. L.; Gurunathan, S.; Kaminker, P.; Tessarollo, L.; Campisi, J.; Hodes, R. J.
  3. Molecular and Cellular Biology. 2006, MAR; 26(6): 2037-2043.
  1. 14.   Comprehensive analysis of CDKN2A (p16(INK4A)/p14(ARF)) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma
  2. Laud, K.; Marian, C.; Avril, M. F.; Barrois, M.; Chompret, A.; Goldstein, A. M.; Tucker, M. A.; Clark, P. A.; Peters, G.; Chaudru, V.; Demenais, F.; Spatz, A.; Smith, M. W.; Lenoir, G. M.; Bressac-de Paillerets, B.; French Hereditary Melanoma Study, G.
  3. Journal of Medical Genetics. 2006, Jan; 43(1): 39-47.
  1. 15.   Low level, long-term inorganic arsenite exposure causes generalized resistance to apoptosis in cultured human keratinocytes: Potential role in skin co-carcinogenesis
  2. Pi, J. B.; He, Y. Y.; Bortner, C.; Huang, J. L.; Liu, J.; Zhou, T.; Qu, W.; North, S. L.; Kasprzak, K. S.; Diwan, B. A.; Chignell, C. F.; Waalkes, M. P.
  3. International Journal of Cancer. 2005, AUG 10; 116(1): 20-26.
  1. 16.   The nitric oxide prodrug, V-PYRRO/NO, protects against cadmium toxicity and apoptosis at the cellular level
  2. Qu, W.; Liu, J.; Fuquay, R.; Shimoda, R.; Sakurai, T.; Saavedra, J. E.; Keefer, L. K.; Waalkes, M. P.
  3. Nitric Oxide-Biology and Chemistry. 2005, MAR; 12(2): 114-120.
  1. 17.   Inhibition of melanoma growth and metastasis by ATF2-derived peptides
  2. Bhoumik, A.; Gangi, L.; Ronai, Z.
  3. Cancer Research. 2004, NOV 15; 64(22): 8222-8230.
  1. 18.   Mutant K-ras(V12) increases COX-2, peroxides and DNA damage in lung cells
  2. Maciag, A.; Sithanandam, G.; Anderson, L. M.
  3. Carcinogenesis. 2004, NOV; 25(11): 2231-2237.
  1. 21.   Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: A randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma
  2. Smith, J. W.; Kurt, R. A.; Baher, A. G.; Denman, S.; Justice, L.; Doran, T.; Gilbert, T.; Alvord, W. G.; Urba, W. J.
  3. Journal of Immunotherapy. 2003 26(2): 130-138.
  1. 22.   Ink4a/Arf deficiency promotes ultraviolet radiation-induced melanomagenesis
  2. Recio, J. A.; Noonan, F. P.; Takayama, H.; Anver, M. R.; Duray, P.; Rush, W. L.; Lindner, G.; De Fabo, E. C.; DePinho, R. A.; Merlino, G.
  3. Cancer Research. 2002 62(22): 6724-6730.
  1. 23.   Establishing connections between microarray expression data and chemotherapeutic cancer pharmacology
  2. Wallqvist, A.; Rabow, A. A.; Shoemaker, R. H.; Sausville, E. A.; Covell, D. G.
  3. Molecular Cancer Therapeutics. 2002 1(5): 311-320.
  1. 24.   Rarity of CDK4 germline mutations in familial melanoma
  2. Goldstein, A. M.; Chidambaram, A.; Halpern, A.; Holly, E. A.; Guerry, D.; Sagebiel, R.; Elder, D. E.; Tucker, M. A.
  3. Melanoma Research. 2002 12(1): 51-55.
  1. 25.   Neonatal sunburn and melanoma in mice - Severe sunburn in newborn, but not adult, mice is linked with melanoma in later life
  2. Noonan, F. P.; Recio, J. A.; Takayama, H.; Duray, P.; Anver, M. R.; Rush, W. L.; De Fabo, E. C.; Merlino, G.
  3. Nature. 2001 413(6853): 271-272.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel